UnitedHealth ( UNH) also beat Wall Street estimates for its Q3 results and raised its FY25 EPS guidance. The company reported ...

The company now expects 2025 non-GAAP EPS of $5.35-$5.39, compared with the $5.25 consensus and its previous guidance of $5.15-$5.30. Q4 non-GAAP EPS guidance is $1.27-$1.31 vs. the average analyst ...

This special report focuses on the escalating infighting within the AIADMK, with senior leader K.A. Sengottaiyan launching a ...

Infrastructure construction company MasTec (NYSE:MTZ) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 22% year on year to $3.97 billion. The company’s full-year ...

Bitcoin's action of late hasn't been great, but the price did rise nearly 7% in the three months ended September 30, boosting ...

Square Pharmaceuticals, the country's leading drug manufacturer, reported a 15% rise in consolidated net profit to Tk2,397 crore for FY25, driven by strong performances from its subsidiaries and ...

Google published its Q3 2025 earnings report late this afternoon. The company reported $102.3 billion, beating the ...

Q3 2025 Management View Beth Wozniak, CEO & Chairman of the Board, highlighted, "Our portfolio transformation to become a ...

First Solar beats Q3 sales estimates and reports record module shipments. Analyst raises price target to $150 despite supply ...

This article was updated to correct financial comparisons between GAAP and non-GAAP results. The earlier version incorrectly ...

Tesla’s Q3 2025 earnings report is out now and provides a full rundown of the company’s financial performance over the past ...

South African poultry producer Astral Foods expects its earnings per share (EPS) to rebound for the 12 months to the end of ...